Patient Information: Summary of Product Characteristics
Ludiomil75mg film-coated tabletsmaprotiline hydrochloride
Read the entire summary of product characteristics carefully before starting to take this medication, as it contains important information for you.
Contents of the Summary of Product Characteristics:
Each Ludiomil 75mg tablet contains 75mg of maprotiline hydrochloride.
It belongs to the group of tetracyclic antidepressants. The known action and clinical use of maprotiline are similar to those of tricyclic antidepressants (TCAs), such as amitriptyline. Ludiomil helps to alleviate symptoms of depression, such as anxiety, sadness, loss of interest, difficulty performing daily activities, nervousness, and sleep disorders.
Ludiomil is indicated for adults over 18 years of age.
Do not take Ludiomil
if you are allergic to other cyclic antidepressants, such as imipramine, amitriptyline, and doxepin.
If you have a severe cardiac disorder or have recently suffered a myocardial infarction.
If you are taking alcohol, narcotics, or medications that affect your mental state.
If you have thought about harming yourself or taking your own life.
If you suffer from frequent and severe constipation.
Ludiomil may reduce the convulsive threshold, so if you have an increased tendency to seizures (e.g., withdrawal syndrome after abruptly stopping benzodiazepines or barbiturates), this may lead to an increase in seizures.
Tell your doctor if you experience any of the following symptoms during treatment with this medication:
Suicidal thoughts, worsening depression, or anxiety disorders
If you suffer from depression or anxiety disorders, you may occasionally experience suicidal thoughts or self-harm. These symptoms may intensify when starting treatment with antidepressants for the first time, as these medications take some time to take effect, usually a few weeks, sometimes even longer.
The likelihood of such thoughts may increase if:
If you have suicidal thoughts or self-harm desires, you should contact the doctor treating you or go directly to the hospital.
It may be helpful to inform a relative or close friendabout your depression or anxiety disorder and ask them to read this summary of product characteristics. You can also ask them to assess whether your depression or anxiety is worsening or if they are concerned about changes in your behavior.
It is essential that the doctor regularly evaluates the treatment effects. This will allow for dose adjustment and reduction of side effects.
During follow-up visits, the doctor may recommend blood tests and analysis of kidney and liver function.
Maprotiline may cause dry mouth and increase the risk of dental caries. For this reason, it is necessary to attend regular dental check-ups during prolonged treatment.
Before undergoing dental or surgical procedures, you should inform the doctor that you are taking Ludiomil.
Ludiomil may cause high, low, or irregular heart rate. During treatment with maprotiline, the doctor may recommend monitoring blood pressure and cardiac function.
In combination with antidiabetic medications, Ludiomil may cause a reduction in blood glucose levels. Patients with diabetes should closely monitor their blood glucose levels.
The administration of Ludiomil may make your skin more sensitive to sunlight. Even brief exposure to the sun can cause eruptions, itching, redness, or skin discoloration. Stay away from direct sunlight, wear sunglasses, and protect yourself with suitable clothing.
In predisposed and elderly patients, antidepressants may cause confusion or unusual thoughts, especially at night. If this occurs, it usually disappears on its own a few days after stopping the medication.
Abrupt withdrawal or dose reduction should be avoided due to the possible appearance of side effects.
Taking Ludiomil with other medications
Tell your doctor or pharmacist if you are taking, have recently taken, or may need to take any other medication.
Some medications may influence the effects of Ludiomil and vice versa, for example:
It is essential to inform your doctor about the use of any of the above medications. It may be necessary to adjust the dose of Ludiomil or interrupt treatment with one of the medications.
Taking Ludiomil with food, drinks, and alcohol
You should inform your doctor if you regularly consume alcohol. This medication may enhance the effect of alcohol, which can increase drowsiness and alter coordination.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before taking this medication.
Pregnancy
Maprotiline should not be taken during pregnancy, unless a doctor has clearly recommended its administration.
Breastfeeding
Your doctor should be informed that you are breastfeeding. Maprotiline passes into breast milk, so it is advisable to suspend breastfeeding if you are being treated with Ludiomil.
Driving and using machines
Maprotiline may cause drowsiness, blurred vision, dizziness, or other central nervous system side effects. If these occur, you should not drive, operate machinery, or perform other potentially hazardous activities. Alcohol consumption may increase these effects.
Ludiomil contains lactose
Ludiomil contains a sugar called lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Do not exceed the recommended dose. Take this medication until your doctor tells you to stop.
During treatment with Ludiomil, you should remain under medical supervision.
Your doctor will decide the most suitable dose for you based on your age and the severity of your symptoms.
Adults
The recommended dose is within the range of 75 to 150mg per day. Depending on the severity of the symptoms, the patient's response, and tolerance to treatment, it can be started with 25mg (one to three times a day) or 75mg (once a day) and gradually increased to an effective dose. Ludiomil should be taken according to the doctor's prescription. Do not exceed the prescribed dose or take the medication more frequently or for a longer period than indicated by your doctor.
Elderly patients (over 60 years):
Lower doses are generally recommended. The initial dose should be 25mg once a day. If necessary, the daily dose can be gradually increased at small intervals to 25mg three times a day or 75mg once a day, depending on tolerance and response to treatment.
Use in children and adolescents (under 18 years):
This medication is not recommended for children or adolescents under 18 years of age.
Method of administration
Ludiomil tablets should be swallowed whole with sufficient liquid.
The score line is only for breaking the tablet if you find it difficult to swallow it whole.
If the effect of Ludiomil seems too strong or too weak, tell your doctor or pharmacist.
Duration of treatment
Patients should take Ludiomil for several weeks before they start to feel better. The treatment should not be interrupted without consulting the doctor. The responsible doctor should decide whether to gradually reduce the dose before stopping treatment. This procedure will prevent the deterioration of the patient's condition and reduce the risk of withdrawal symptoms associated with sudden interruption of treatment, such as headache, nausea, vomiting, abdominal pain, diarrhea, insomnia, nervousness, and anxiety.
If you take more Ludiomil than you should
If you accidentally take more tablets than prescribed by your doctor, you should seek immediate help at the nearest medical office or hospital.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested. Bring the medication packaging with you.
The following symptoms usually occur within several hours after an overdose: drowsiness, loss of consciousness, coma, convulsions, low blood pressure, rapid, slow, or irregular heart rate, cardiac arrest, restlessness, agitation, altered motor coordination, and muscle rigidity, difficulty breathing, vomiting, fever, cardiovascular shock, heart failure, blue discoloration of the skin, dilated pupils, sweating, and reduced urine production or suppression of urine production.
If you forget to take Ludiomil
If you forget to take a dose of Ludiomil, take the missed dose as soon as possible and take the next dose at the usual time. If it is almost time for the next dose, do not take the missed dose, but take the next dose at the scheduled time. Do not take a double dose to make up for missed doses.
If you stop taking Ludiomil
Do not stop taking the medication without consulting your doctor first. The doctor will gradually reduce the dose before stopping treatment to avoid nausea, vomiting, anxiety attacks, diarrhea, insomnia, headache, nervousness, and anxiety.
If you have any further questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Some side effects can be serious; if you experience any of the following side effects, stop taking the medicine and seek medical attention immediately:
If you experience any of the above side effects, inform your doctor immediately,as it may be essential to adjust the dose or change the treatment.
Very Common Side Effects(may affect more than 1 in 10 people)
Common Side Effects(may affect up to 1 in 100 people)
Rare Side Effects(may affect up to 1 in 1000 people)
Very Rare Side Effects(may affect up to 1 in 10,000 people)
Reporting of Adverse Effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Store in the original packaging. Store at a temperature below 30°C. Do not use if the packaging is damaged or shows signs of having been opened.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the box or packaging after "CAD". The expiration date is the last day of the month indicated.
Medicines should not be thrown away through the sewage system or in the trash. Deposit the packaging and medicines that are no longer needed at the SIGRE point in the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that are no longer needed. This will help protect the environment.
Composition of Ludiomil
The active ingredient is maprotiline hydrochloride
Ludiomil 75 mg: Each film-coated tablet contains 75 mg of maprotiline hydrochloride.
The other components are:
Ludiomil 75 mg: lactose, magnesium stearate, stearic acid, talc, tricalcium phosphate, corn starch, hypromellose, yellow iron oxide (E172), red iron oxide (E172), polysorbate 80, titanium dioxide (E171).
Appearance of the Product and Package Contents
Ludiomil 75 mg film-coated tablets are reddish-brown, round, biconvex tablets, with a diameter of approximately 8 mm and with "F/S" marked on one side. Packages containing 28 and 500 tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder
Amdipharm Limited
Temple Chambers
3 Burlington Road
Dublin 4
Ireland
Manufacturer
CENEXI
52 rue Marcel et Jacques Gaucher - Fontenay Sous Bois
94120 – France
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Ferrer Internacional, S.A.
Gran Vía Carlos III, 94
08028 Barcelona Spain
Date of the Last Revision of this Prospectus:November 2024
Detailed and updated information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of LUDIOMIL 75 mg FILM-COATED TABLETS in October, 2025 is around 6.38 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.